Different Effects of Delayed Clamping on Neonatal Bilirubin Levels Between Pregnant Women With Intrahepatic Cholestasis of Pregnancy and Normal Pregnant Women
Intrahepatic Cholestasis of Pregnancy
About this trial
This is an interventional prevention trial for Intrahepatic Cholestasis of Pregnancy focused on measuring Intrahepatic cholestasis during pregnancy, neonatal bilirubin, bilirubin, ICP, neonatal jaundice
Eligibility Criteria
Inclusion Criteria: The pregnant woman is born at a gestational age of 37-40 weeks; The pregnant woman has a single child; Regular obstetric examination durinv pregnancy with complete obstetric examination data was diagnosed as intrahepatic cholestasis of pregnancy(ICP). Exclusion Criteria: Pregnancy complicated with medical and surgical diseases, such as thyroiddysfunction and chronic hypertension; Insufficiency of vital organ function or complicated tumor; Pregnant women with other pregnancy complications besides ICP, such as preeclampsia, etc.
Sites / Locations
- department of obstetrics of Second Affiliated Hospital of Wenzhou Medical UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Other
Experimental
Other
Experimental
ICC in pregnant women with ICP
DCC in pregnant women with ICP
ICC in normal pregnant women
DCC in normal pregnant women
Immediate cord clamping group in pregnant women with intrahepatic cholestasis of pregnancy
Delayed cord clamping group in pregnant women with intrahepatic cholestasis of pregnancy
Immediate cord clamping group in normal pregnant women
Delayed cord clamping group in normal pregnant women